Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH)
about
Frequency of uterine sarcomas in patients admitted for uterine fibroid surgery.Comment on the New DGGG AWMF S3-Guideline on Hysterectomy, or a Plea for LAVH as the Gold Standard for Total Hysterectomy Procedures.Uterine fibroid management: from the present to the future.Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures.First clinical experiences using a new in-bag morcellation system during laparoscopic hysterectomy.Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.Morcellation of occult uterine malignancies: an Australian single institution retrospective study.A new in-bag system to reduce the risk of tissue morcellation: development and experimental evaluation during laparoscopic hysterectomy.Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.Options on fibroid morcellation: a literature review.Factors for a Successful Laparoscopic Hysterectomy in Very Large Uteri.Laparoscopic Supracervical Hysterectomy with In-Bag Morcellation in Very Large Uterus.Survey among ESGE members on leiomyosarcoma morcellation incidence.Uterine fibroids - what's new?In-Bag Morcellation as a Routine for Laparoscopic Hysterectomy.Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q.
P2860
Q33762552-F4CA663F-213D-4808-803B-ED408A8C6BA4Q36839751-B9F0CCCD-C662-4E87-A7AA-6EBE698987C9Q38837038-32C4C88D-B69D-4C10-8CEE-F59ADA32FFD5Q39737170-0A09B640-91F3-4FAA-BEBF-337DABC9A92FQ39888089-E194261A-A4EC-41FE-BCDA-C870FF1A9B61Q40185701-F1120136-EA95-47B4-AF9C-E5F105900A3BQ40455397-352AAA9A-68A4-4126-AA9D-5D9F1F6E6B4FQ40599957-017FCB3C-EAFF-459F-9976-92D8F93485F3Q40817407-BE4D55A4-DCD6-4C6F-9BD3-E90F2540A516Q42692459-7E2D11A4-1883-46EB-8179-AFF92E68413FQ43176388-BF491553-0A73-4984-986A-9BA415BA0C99Q43379213-0B49F9BA-5079-4F88-AE7E-02EB79BC3C20Q47129444-7130E830-18B7-4C17-86EA-2EE01F9EF64EQ47134369-B70D9D88-AEC7-4FCB-A2F6-9261F9ACCC09Q47135445-09615FEB-B303-43DA-B3E4-F47FB7027882Q48274971-900532F9-464C-4F3F-A930-45DED06AB3EDQ50906835-D8961DD4-5549-4D2C-83D8-321FBD2280ECQ55385567-9A66DF03-4F71-4D02-A8EF-B84F13FA7EC6
P2860
Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH)
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@ast
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@en
type
label
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@ast
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@en
prefLabel
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@ast
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@en
P2860
P1476
Malignancy rate of 10,731 uter ...... racervical hysterectomy (LASH)
@en
P2093
Garri Tchartchian
Rudy Leon De Wilde
P2860
P2888
P304
P356
10.1007/S00404-015-3696-Z
P50
P577
2015-03-28T00:00:00Z